NovoCure Limited (NVCR) SEC Filings & Earnings Calls

Cybersecurity incident with patient data exposure could lead to regulatory fines, legal liabilities, and reputational damage. Company currently assesses no material impact but investigation ongoing.

“The exposed data included: internal Company patient ID numbers for over 1,400 U.S. patient records... patient data for fewer than 50 other patients in the western U.S. that included additional identifying information. At this time, we do not believe that this cybersecurity incident will have a material impact... however... we are continuing to ascertain addi” · word for word

Clinical trial failure

“TRIDENT did not show a statistically significant improvement in the primary endpoint of overall survival.” · word for word

Tariff exposure

“Our current analysis of the global tariff environment leads us to believe there should not be a material impact to gross margins in the short-term and we are actively working to mitigate any potential impacts in the medium to long-term.” · word for word

Geopolitical risk (Israel conflict)

“As of the date of this filing, we believe that there is no immediate risk to our business facilities or operations.” · word for word

Dependence on regulatory approvals for new indications; FDA decision on brain metastases from NSCLC expected Q4 2026.

“Decision by the U.S. Food and Drug Administration on the premarket approval application for use of TTFields therapy for the treatment of brain metastases from non-small cell lung cancer (Q4 2026).” · word for word

One-time tariff refund of $4.9 million boosted gross margin; underlying margin may be lower without such benefits.

“Cost of revenues in the quarter benefitted from a one-time $4.9 million tariff refund.” · word for word

Net loss of $15.7 million indicates continued unprofitability, though improving.

“Net loss for the quarter was $15.7 million.” · word for word

Commercial adoption risk; reimbursement and market access in Europe may take time.

“CE Mark approval is a regulatory milestone but does not guarantee rapid commercial uptake; reimbursement negotiations with national agencies are pending.”

Phase 3 TRIDENT trial failed to meet primary endpoint, reducing likelihood of label expansion for earlier TTFields use in GBM.

“The trial did not demonstrate a statistically significant improvement in the primary endpoint of overall survival for the Early Start Arm compared to the Maintenance Start Arm.” · word for word

Tariff Exposure

“Our current analysis of the global tariff environment leads us to believe there should not be a material impact to gross margins in the short-term and we are actively working to mitigate any potential impacts in the medium to long-term.” · word for word

Geopolitical Risk (Israel)

“Since October 2023, the State of Israel has been in a state of war. As of the date of this filing, we believe that there is no immediate risk to our business facilities or operations.” · word for word

Cash Burn

“Net cash provided by (used in) operating activities (13,517) (35,665)” · word for word

Net loss and negative adjusted EBITDA; high operating expenses

“Net loss for the quarter was $71.1 million; Adjusted EBITDA was $(0.3) million.” · word for word

Optune Lua commercial adoption risk

“Optune Lua Active Patients 20% weight, 156 Active Patients, —% score, —% weighted score. ... our Board and Compensation Committee also determined that it was appropriate under the circumstances to modify the aggregate achievement level by a downward adjustment of 28% to reflect that Optune Lua Active Patients significantly underperformed expectations and tha”

Key executive turnover risk

“Ms. Cordova resigned as Chief Executive Officer and director on November 30, 2025. Dr. Leupin resigned as Chief Medical Officer on February 25, 2026.” · word for word

Clinical trial discontinuation risk

“Our LUNAR-4 trial was discontinued in August 2025.” · word for word

Tariff Impact on Margins

“Our current analysis of the global tariff environment leads us to believe there should not be a material impact to gross margins in the short-term and we are actively working to mitigate any potential impacts in the medium to long-term.” · word for word

Single-Source Supplier Risk

“Our supply chain teams have increased stock levels to mitigate distribution and service risks from our suppliers in Israel, some of whom are single-source suppliers.” · word for word

Liquidity Risk

“We have incurred significant losses and cumulative negative cash flows from operations with only limited and intermittent operating profits since our founding in 2000.” · word for word

CMS billing revocation risk

“billing privileges... revoked... due to an administrative process issue”

Tariff exposure impacting margins

“increased tariffs” · word for word

Temporary billing disruption risk resolved; no substantive compliance failure.

“The Company was cited for an administrative process issue relating to the Company's triannual re-validation and not due to a substantive failure.” · word for word

Commercial execution risk for new indication; requires sales force expansion and reimbursement.

“New product launch requires commercial infrastructure; no revenue guidance provided.”

CMS billing privilege revocation creates material revenue and cash flow risk; reinstatement timeline uncertain; potential inability to recover past-due billings.

“billing privileges for its products were revoked retroactive to December 17, 2025... unable to predict with reasonable certainty when this will occur” · word for word

Preliminary results subject to final adjustments; CMS billing issue may impact future revenue.

“The financial data contained therein are unaudited, preliminary, based upon the Company’s good faith estimates and subject to completion of the Company’s financial closing procedures.” · word for word

CEO transition may cause short-term uncertainty; new CEO was previously President, mitigating risk.

“CEO resignation and appointment of new CEO.”

Convertible note maturity

“The Notes mature on November 1, 2025, unless earlier repurchased, redeemed or converted as set forth in the Notes.” · word for word

Operating losses continue

“Operating income (loss) $(36,021) for three months ended September 30, 2025 compared to $(32,092) for the same period in 2024.”

Gross margin pressure from product mix, tariffs, and inventory obsolescence.

“Gross margin for the quarter was 73% compared to 77% in the prior year.” · word for word